S Joseph Tarnowski

Title: S Joseph Tarnowski: Innovator in Biopharmaceuticals

Introduction

S Joseph Tarnowski is a notable inventor based in Sunnyvale, CA, with a focus on biopharmaceutical innovations. He holds a total of 4 patents that contribute significantly to the field of recombinant polypeptides and pharmaceutical formulations.

Latest Patents

One of his latest patents is titled "Expression of recombinant polypeptides with improved purification." This patent describes an improved method for expressing peptides as fusion proteins, utilizing a carrier for a heterologous peptide to create a fusion protein with a high isoelectric point (pI). The high pI facilitates the separation of the fusion protein from other host cell proteins, as well as the separation of the carrier from the peptide after cleavage. Another significant patent is "Formulations for stabilizing fibroblast growth factor," which provides pharmaceutical formulations and a method for their preparation. These formulations stabilize basic fibroblast growth factor (bFGF), making it less susceptible to oxidation or metal-induced aggregation by including a chelating agent effective in stabilizing the bFGF.

Career Highlights

Throughout his career, S Joseph Tarnowski has worked with several prominent companies, including Scios Nova, Inc. and California Biotechnology Inc. His contributions to these organizations have been instrumental in advancing biopharmaceutical research and development.

Collaborations

He has collaborated with notable professionals in the field, including Sandra Hilliker and W Scott Willett, enhancing the impact of his work through teamwork and shared expertise.

Conclusion

S Joseph Tarnowski's innovative contributions to biopharmaceuticals through his patents and collaborations highlight his significant role in advancing medical science. His work continues to influence the development of effective therapeutic solutions.